Protect Pharmaceutical Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2017	FY 2016	FY 2015	FY 2014	FY 2013	2012 - 2008
Period Ending	Jun '18 Jun 30, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016	Dec '15 Dec 31, 2015	Dec '14 Dec 31, 2014	Dec '13 Dec 31, 2013	2012 - 2008
Net Income	-0.02	-0.12	-0.04	-0.64	0.46	-0.02	Upgrade
Stock-Based Compensation	-	-	0	0.01	0.01	0.01	Upgrade
Other Operating Activities	0	0.1	0.01	0.61	-0.46	0.02	Upgrade
Change in Accounts Payable	0	0.02	0.01	0.01	-0.01	-0	Upgrade
Change in Other Net Operating Assets	0.01	0.01	-	-	-	-	Upgrade
Operating Cash Flow	0	-	-0.01	-0.02	-0	-0	Upgrade
Short-Term Debt Issued	-	-	0.01	0.02	-	-	Upgrade
Total Debt Issued	0.02	-	0.01	0.02	-	-	Upgrade
Net Debt Issued (Repaid)	0.02	-	0.01	0.02	-	-	Upgrade
Financing Cash Flow	0.02	-	0.01	0.02	-	-	Upgrade
Net Cash Flow	0.02	-	-0	-0	-0	-0	Upgrade
Levered Free Cash Flow	-	-	-	-0.03	-0.49	0.01	Upgrade
Unlevered Free Cash Flow	-	-	-	-0.03	-0.49	0.01	Upgrade
Change in Working Capital	0.01	0.02	0.01	0.01	-0.01	-0	Upgrade

Source: S&P Capital IQ. Standard template. Financial Sources.